Bing

SEARCH HISTORY

Peregrine Pharmaceuticals Inc. (NASDAQ: PPHM) may be on the verge of something big with its anticancer drugs. The shares soared almost 50% on Wednesday, and the stock was indicated higher in both Wednesday’s after-hours session and in …
24/7 Wall ST · 3/6/2014
PPHM-- along with other Ebola-related stocks -- is bucking the trend lower, up 14.3% at $1.60. The company -- which will host its annual shareholder meeting tomorrow -- this morning said it will test its experimental Ebola antibody, and traders are waxing ...
Schaeffer's Investment Research · ByAndrea Kramer · 10/15/2014
Peregrine Pharmaceuticals, Inc. (NASDAQ:PPHM) [Trend Analysis] announced the peer-reviewed ... monthly performance was -3.57%. The stock price is moving down from its 20 days moving average with -7.22% and isolated negatively from 50 days …
emarketsdaily.com · 4/1/2015
More from Bing News
The development of new cancer treatments is always ongoing and investors should monitor for emerging ideas and stocks. Companies like Propanc (OTC: PPCH), Cerulean Pharma (NASDAQ: CERU), Peregrine Pharma (NASDAQ: PPHM), and Verastem …
Stockhouse · 5/17/2015
New York, NY - (ACCESSWIRE) - 11/11/2013 - Growing Stock Report initiates its NASDAQ Healthcare Active Stock Watch List adding Oxygen Biotherapeutics, Inc. (NASDAQ:OXBT), Horizon Pharma, Inc. (NASDAQ:HZNP), Peregrine Pharmaceuticals, Inc.
4 Traders · 11/11/2013
Point Roberts, WA - December 7, 2011 - Investorideas.com, an investor research portal specializing in sector research including biotech and pharma stocks, issues an investor alert for some of the top trading stocks in the sector for Tuesday, December 06 …
investorideas.com · 12/7/2011
PPHM) (NASDAQ: PPHMP) today announced that its Board of Directors has declared a quarterly cash dividend payment on the Company's 10.50% Series E Convertible Preferred Stock (the "Series E Preferred Stock"). The quarterly dividend on the Series …
Reuters · 12/9/2014
TUSTIN, CA--(Marketwired - Feb 5, 2014) - Peregrine Pharmaceuticals, Inc. (NASDAQ: PPHM) (the "Company"), announced today that it intends to offer and sell shares of its newly-designated 10.50% Series E Convertible Preferred Stock (the "Series E …
marketwired.com · 2/5/2014
March 10, 2015 (GLOBE NEWSWIRE) -- Peregrine Pharmaceuticals, Inc. (Nasdaq:PPHM) (Nasdaq:PPHMP) today announced that its Board of Directors has declared a quarterly cash dividend payment on the Company's 10.50% Series E Convertible …
GlobeNewswire · 3/10/2015
Explore the tool here. Article printed from InvestorPlace Media, http://investorplace.com/2014/01/4-biotechnology-stocks-to-sell-now-irwd-tsrx-pphm/.
Investor Place · 1/15/2014